C O R E C :
The aim of the Bioinformatics Core ('Core C ) is to identify and characterize genes and pathway activation patterns cnjcial for gliomagenesis or GBM homeostasis. Core C will use commonly applied methods for DNA copy analysis and gene expression analysis to identify and characterize genes and pathway activation patterns crucial for gliomagenesis or GBM homeostasis, on data from the model systems developed by each of the Projects. We will work closely with the project investigators to a) provide analytical support to their research and b) suggest follow up experiments guided by our genomic data analysis. We will apply commonly used analytical methods for preprocessing of Affymetrix 3'UTR and exon expression array data, such as quantile normalization and Robust Multi-array Averaging (RMA);parametric methods for identifying differentially expressed genes such as Significance Analysis of Microarrays (SAM) and limma, and Gene Set Enrichment Analysis (GSEA) as implemented in R (www.r-project.org) and Bioconductor (www.bioconductor.org). For analyzing DNA copy number data, we will use the GIST1C2.0 approach as implemented in Matlab (Mermel C et al. Genome Biology 2011) for data normalization and identification of genomic targets. For analysis of sequencing data we will make use of fast short read alignment methods such BWA, and the processing abilities of tools such as samtools (http://samtools.sourceforge.net) and the Genome Analysis Toolkit (www.broadinstitute.org/gsa/wiki/index.php/The_Genome_Analysis_Toolkit). Prior to analysis of xenograft data, we will correct for crossreactivity of mouse mRNA to the Affymetrix platforms that are being used, by mapping probes from each GeneChip to mm 10. We will then generate probe sets for each human gene only including probes that did not show significant alignment to mmlO. We will project findings from the mouse model from Project 2 through mapping of mouse genes to human genes using Ensembl. We will use our intimate knowledge of the data from The Cancer Genome Atlas to project our findings on human GBM data sets. Our core personnel are experienced in analysis of genomic data types and interpretation of the results in the context of larger studies. Moreover, we have been closely working with the TCGA analysis working groups and have shown the ability to collaborate and communicate. This ensures a productive research environment in which the different aims of this project proposal can effectively come to fruition.
Malignant gliomas are now understood to consist of a variety of subtypes rather than a single disease. This Core will sen/e to elucidate the distinguishing signatures of these tumor subtypes in an effort to determine the underiying basis of their initiation and sensitivity or resistance to therapy.
|GalbÃ¡n, C J; Hoff, B A; Chenevert, T L et al. (2016) Diffusion MRI in early cancer therapeutic response assessment. NMR Biomed :|
|Chen, Daiqin; Dougherty, Casey A; Yang, Dongzhi et al. (2016) Radioactive Nanomaterials for Multimodality Imaging. Tomography 2:3-16|
|Masch, William R; Wang, Page I; Chenevert, Thomas L et al. (2016) Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis. Acad Radiol 23:569-76|
|Van Dort, Marcian E; Hong, Hao; Wang, Hanxiao et al. (2016) Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3-Kinase (PI3K). J Med Chem 59:2512-22|
|Ross, Brian D (2016) Demonstration of an Inline Publication Image Viewer: The Future of Radiological Publishing. Tomography 2:1-2|
|Aryal, Madhava P; Chenevert, Thomas L; Cao, Yue (2016) Impact of uncertainty in longitudinal T1 measurements on quantification of dynamic contrast-enhanced MRI. NMR Biomed 29:411-9|
|Nyati, Shyam; Chator, Areeb; Schinske, Katerina et al. (2016) A Requirement for ZAK Kinase Activity in Canonical TGF-Î² Signaling. Transl Oncol 9:473-481|
|Ceccarelli, Michele; Barthel, Floris P; Malta, Tathiane M et al. (2016) Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell 164:550-63|
|Tang, Ming; Verhaak, Roel Gw (2016) A Molecular Take on Malignant Rhabdoid Tumors. Trends Cancer 2:217-218|
|Lemasson, Benjamin; Wang, Hanxiao; GalbÃ¡n, Stefanie et al. (2016) Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model. Neoplasia 18:82-9|
Showing the most recent 10 out of 140 publications